New nasal spray offers hope for depression patients Who've tried everything else
Symptom relief
Recruiting now
This study is testing whether esketamine nasal spray can help reduce depression symptoms in Korean patients whose depression hasn't improved with at least two standard antidepressant medications. Researchers will measure changes in depression scores over 4 weeks of treatment. The…
Phase: PHASE4 • Sponsor: Janssen Korea, Ltd., Korea • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC